Eli Lilly and Resilience to Pump $750 Million into U.S. Drug Manufacturing
Eli Lilly and contract manufacturer Resilience will invest $750 million to expand pharmaceutical manufacturing capacity in the United States, increasing output of key medicines and creating 400 high-skilled jobs in the Cincinnati, Ohio region. The expanded operations will include production of Lilly’s KwikPen injectable device. The multi-year manuf…